%PDF-1.3
%
1 0 obj
<>stream
uuid:bb6c3714-5885-41bc-b840-3a128546f2c6
uuid:B3ACC101-DF15-880F-4744-1E292B4BD010
2022-02-13T17:06:43-08:00
2022-02-13T17:06:43-08:00
3B2 Total Publishing System 8.07e/W
2008-02-20T13:54:22+05:30
PDFlib PLOP 3.0 (.NET/Win32)/Acrobat Distiller 7.0 (Windows); modified using iText 4.2.0 by 1T3XT
application/pdf
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)1
endstream
endobj
4 0 obj
<>stream
HWnܼC{@.b}"ERb/ EZ\8j^}V?vvwWv(\r4$gΜ367j88Z7T:Voԕћ1o|gQOnѿ8dY&![x+aM?J2ig<"?UA>Ҍ+-lIOCORei۰OƪgL/;#x:UjEaOK_*({O'M5shR
(KהM .&P-ojOf/T
"q)@{hy´AfK&INB\tFNB2`v(6}7UaiMU?v06&J,!D0_K4jG/ sV7cpn\B"`ǰF-i e}N[p<0cB ~
$#X5,I$`U}' q-8Ċűey99 :"ShS2qSN5!mQ\\:)/D4tN%( 5 ٝ)A];vkx&z#EyBa'"
/S56WN05<1Q)Β(dMk.c: n Im8UC\wďo a \#oq"6{$JK&̑9hhV|sNH @*Al:T-
p{
4:A EAN%XSz56
Ġ8*'ޖk~HJ c|\2giFo
>:I"p
ڨIi
F CE=$5W|k n{yIAY3?'4Rv "##/dOFH8,m>HRLV֑R5hgǥE-QbRA>